Amplitude Vascular Systems vs Emulate

Side-by-side comparison of AI visibility scores, market position, and capabilities

Emulate leads in AI visibility (74 vs 36)
Amplitude Vascular Systems logo

Amplitude Vascular Systems

EmergingLife Sciences & BioTech

Intravascular Lithotripsy & Calcified Artery Treatment Devices

Amplitude Vascular Systems (AVS) is a medical device company developing the Pulse IVL system — a high-frequency pulsatile pressure wave device for treating calcified peripheral artery disease; raised $75M+ total;

AI VisibilityBeta
Overall Score
D36
Category Rank
#81 of 198
AI Consensus
86%
Trend
stable
Per Platform
ChatGPT
36
Perplexity
38
Gemini
33

About

Amplitude Vascular Systems (AVS) is a medical device company headquartered in Fremont, California, founded to develop next-generation intravascular lithotripsy (IVL) technology for treating calcified peripheral artery disease (PAD). The company''s flagship product, the Pulse IVL system, delivers high-frequency pulsatile pressure waves through a catheter-based device to fracture calcium deposits in arterial walls — restoring vessel compliance and improving blood flow in patients with calcified, obstructed arteries in the legs, below-the-knee vessels, and other peripheral vascular territories. Calcified PAD is a significant and growing clinical problem, particularly in diabetic patients and the aging population, where conventional balloon angioplasty and stenting are less effective due to hard, calcified lesion morphology.

Full profile
Emulate logo

Emulate

LeaderLife Sciences & BioTech

Organ-on-Chip & Drug Development Tools

Pioneering organ-on-chip platform installed in 150+ labs including 17 of the top 25 biopharma companies; launched AVA™ high-throughput 96-chip system in 2025 and holds the only FDA ISTAND-accepted DILI Organ-Chip.

AI VisibilityBeta
Overall Score
B74
Category Rank
#8 of 198
AI Consensus
73%
Trend
stable
Per Platform
ChatGPT
78
Perplexity
73
Gemini
77

About

Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the microstructure and function of human organs. Founded in 2013 as a spin-out from the Wyss Institute at Harvard University, Emulate's chips model the liver, intestine, lung, kidney, brain, and other organ systems with a fidelity that animal models and traditional cell culture cannot match. The technology was originally developed to reduce drug development attrition rates caused by poor translation from animal studies to human clinical outcomes.

Full profile

AI Visibility Head-to-Head

36
Overall Score
74
#81
Category Rank
#8
86
AI Consensus
73
stable
Trend
stable
36
ChatGPT
78
38
Perplexity
73
33
Gemini
77
33
Claude
79
37
Grok
68

Key Details

Category
Intravascular Lithotripsy & Calcified Artery Treatment Devices
Organ-on-Chip & Drug Development Tools
Tier
Emerging
Leader
Entity Type
brand
brand

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.